Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-10-30
1999-08-31
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 16, 546 17, A61K 3144, C07D22100
Patent
active
059454288
ABSTRACT:
Compound represented by the structural formula ##STR1## or a pharmaceutically acceptable salt thereof, wherein: a is 0, 1, 2 or 3;
REFERENCES:
patent: 5350852 (1994-09-01), Emonds-Alt et al.
patent: 5434158 (1995-07-01), Shah
patent: 5654316 (1997-08-01), Carruthers et al.
patent: 5688960 (1997-11-01), Shankar
patent: 5691362 (1997-11-01), McCormick et al.
patent: 5696267 (1997-12-01), Reichard et al.
Maggi et al, Eur. J. Pharmacol., 166, (1989), pp. 435-440.
Ellis et al, J. Pharmacol. Exp. Ther., 267, 1 (1993), pp. 95-101.
Furchgott, Pharm. Rev., 7 (1955), pp. 183-265.
Arunlakshana et al, Brit. J. Pharmacol., 14, 48 (1959), pp. 48-58.
Danko et al, Pharmacol. Comm., 1, 3 (1992), pp. 203-209.
Chung et al, Molecular Pharmacol., 48 (1995), pp. 711-716.
Ong, et al, J. Med. Chem., 26 (1983), pp. 981-986.
Aslanian Robert G.
Reichard Gregory A.
Shih Neng-Yang
Magatti Anita W.
Raymond Richard L.
Schering Corporation
Sripada Pavanaram K
LandOfFree
Substituted oximes, hydrazones and olefins as neurokinin antagon does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted oximes, hydrazones and olefins as neurokinin antagon, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted oximes, hydrazones and olefins as neurokinin antagon will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2426588